Prognostic Stage III Breast Cancer AJCC v8 Completed Phase 1 Trials for Methotrexate (DB00563)

Also known as: Prognostic Stage 3 Breast Cancer AJCC v8

IndicationStatusPhase
DBCOND0109635 (Prognostic Stage III Breast Cancer AJCC v8)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03518242Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast CancerTreatment